Comparison of the Sodium valproate and Sodae herbal capsule effects on migraine pain

A comparative survey of the Sodium valproate and Sodae herbal capsule effects on migraine pain

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200126046272N3

Enrollment

Registered

2020-09-27

Start date

2020-07-22

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine. Migraine

Interventions

Intervention 1: Intervention group: The intervention group will take one 720 mg sodae capsule made by Boo Ali Daroo Company, with warm water every night before going to bed for three months. Intervent

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Having more than 3 attacks per month in the last three months Having more than 3 attacks at the base time Start migraines at least one year before entering the project Start migraines before age 50

Exclusion criteria

Exclusion criteria: Chronic tension headaches or other headaches for more than 15 days a month Pregnancy, lactation Patients should not be addicted to alcohol or other illegal substances

Design outcomes

Primary

Measure	Time frame
Severity of migraine. Timepoint: Baseline, Three months after the Baseline. Method of measurement: Based on Headache Disability Scale (MIDAS) and Headache Severity Test (HIT6).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegin Fakhri

Kermanshah University of Medical Sciences

n.fakhri94@yahoo.com+98 83 3826 4447

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026